| 1. |
Atkins D, Eccles M, Flottorp S, et al. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches. The GRADE Working Group. BMC Health Serv Res, 2004, 4(1): 38.
|
| 2. |
Lacchetti C, Guyatt G. Surprising results of randomized trials. In: Guyatt G, Drummond R, eds. Users’ guides to the medical literature: a manual of evidence-based clinical practice. Chicago, IL: AMA Press, 2002.
|
| 3. |
American College of Physicians. Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Intern Med, 1992, 117(12): 1038-1041.
|
| 4. |
Humphrey LL, Chan BK, Sox HC. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Intern Med, 2002, 137(4): 273-284.
|
| 5. |
Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA, 1998, 280(7): 605-613.
|
| 6. |
Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA, 2002, 288(3): 321-333.
|
| 7. |
Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med, 1991, 324(12): 781-788.
|
| 8. |
Antman EM, Lau J, Kupelnick B, et al. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA, 1992, 268(2): 240-248.
|
| 9. |
Committee on Infectious Diseases. Aspirin and Reye syndrome. Pediatrics, 1982, 69(6): 810-812.
|
